Cartesian Therapeutics, Inc. (RNAC)
NASDAQ·Healthcare·Biotechnology
$9.61
+19.17%
Mkt Cap $234.55M
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (5 analysts)
$20.50
Range $16.00 – $25.00
Implied Upside
+113.4%
Consensus $20.50 vs current $9.61
NASDAQ·Healthcare·Biotechnology
$9.61
+19.17%
Mkt Cap $234.55M
Buy
11
Hold
0
Sell
0
Price Target (5 analysts)
$20.50
Range $16.00 – $25.00
+113.4%
Consensus $20.50 vs current $9.61